HEADER TRANSFERASE/TRANSFERASE INHIBITOR 01-APR-17 5VCY TITLE CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH TITLE 2 BOSUTINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2- COMPND 3 INHIBITORY KINASE; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 75-362; COMPND 6 SYNONYM: MYT1 KINASE; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PKMYT1, MYT1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)-RIPL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4 KEYWDS KINASE DOMAIN, CELL CYCLE, TYROSINE- AND THREONINE-SPECIFIC KINASE, KEYWDS 2 MEMBRANE-ASSOCIATED PROTEIN KINASE, TRANSFERASE, INHIBITOR, KEYWDS 3 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.-Y.ZHU,E.SCHONBRUNN REVDAT 4 04-OCT-23 5VCY 1 REMARK REVDAT 3 11-DEC-19 5VCY 1 REMARK REVDAT 2 11-OCT-17 5VCY 1 JRNL REVDAT 1 23-AUG-17 5VCY 0 JRNL AUTH J.Y.ZHU,R.A.CUELLAR,N.BERNDT,H.E.LEE,S.H.OLESEN,M.P.MARTIN, JRNL AUTH 2 J.T.JENSEN,G.I.GEORG,E.SCHONBRUNN JRNL TITL STRUCTURAL BASIS OF WEE KINASES FUNCTIONALITY AND JRNL TITL 2 INACTIVATION BY DIVERSE SMALL MOLECULE INHIBITORS. JRNL REF J. MED. CHEM. V. 60 7863 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28792760 JRNL DOI 10.1021/ACS.JMEDCHEM.7B00996 REMARK 2 REMARK 2 RESOLUTION. 1.56 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.56 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.05 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 41719 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.140 REMARK 3 FREE R VALUE : 0.178 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1252 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.0579 - 3.2441 0.93 4506 140 0.1511 0.1659 REMARK 3 2 3.2441 - 2.5751 0.98 4507 139 0.1501 0.1942 REMARK 3 3 2.5751 - 2.2497 0.99 4541 141 0.1330 0.1764 REMARK 3 4 2.2497 - 2.0440 0.99 4524 140 0.1183 0.1519 REMARK 3 5 2.0440 - 1.8975 0.99 4504 139 0.1168 0.1655 REMARK 3 6 1.8975 - 1.7856 1.00 4516 140 0.1237 0.1971 REMARK 3 7 1.7856 - 1.6962 0.99 4494 139 0.1373 0.1952 REMARK 3 8 1.6962 - 1.6224 0.99 4433 137 0.1521 0.2404 REMARK 3 9 1.6224 - 1.5599 0.99 4442 137 0.1628 0.2243 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.120 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 17.080 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.19 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.31 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2446 REMARK 3 ANGLE : 1.179 3307 REMARK 3 CHIRALITY : 0.043 340 REMARK 3 PLANARITY : 0.006 437 REMARK 3 DIHEDRAL : 14.751 923 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5VCY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-APR-17. REMARK 100 THE DEPOSITION ID IS D_1000227245. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-OCT-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : ROSENBAUM-ROCK DOUBLE-CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41721 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.560 REMARK 200 RESOLUTION RANGE LOW (A) : 36.048 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 2.833 REMARK 200 R MERGE (I) : 0.04800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.9400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.56 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.60 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.82 REMARK 200 R MERGE FOR SHELL (I) : 0.35800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.860 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5VCV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.77 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14 MG/ML MYT1, 50 MM HEPES PH 7.5, 0.5 REMARK 280 MM DTT, 0.05 M POTASSIUM CHLORIDE, 17.5 (V/V) % PENTAERYTHRITOL REMARK 280 PROPOXYLATE (5/4 PO/OH), 1.5 MM BOSUTINIB, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.31500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.83000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.50000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 56.83000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.31500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 27.50000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 960 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15140 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 11.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -22 REMARK 465 HIS A -21 REMARK 465 HIS A -20 REMARK 465 HIS A -19 REMARK 465 HIS A -18 REMARK 465 HIS A -17 REMARK 465 HIS A -16 REMARK 465 SER A -15 REMARK 465 SER A -14 REMARK 465 GLY A -13 REMARK 465 VAL A -12 REMARK 465 SER A 73 REMARK 465 MET A 74 REMARK 465 HIS A 75 REMARK 465 GLN A 76 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 619 O HOH A 705 2.08 REMARK 500 OD1 ASP A 251 O HOH A 501 2.10 REMARK 500 O HOH A 674 O HOH A 715 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 565 O HOH A 691 4445 1.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 87 61.90 -168.19 REMARK 500 ASP A 233 46.31 -145.13 REMARK 500 ARG A 244 54.73 27.75 REMARK 500 ASP A 251 72.35 70.38 REMARK 500 GLU A 265 -3.43 63.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DB8 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PEG A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 406 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5VCV RELATED DB: PDB REMARK 900 RELATED ID: 5VCW RELATED DB: PDB REMARK 900 RELATED ID: 5VCX RELATED DB: PDB REMARK 900 RELATED ID: 5VCZ RELATED DB: PDB REMARK 900 RELATED ID: 5VD0 RELATED DB: PDB REMARK 900 RELATED ID: 5VD1 RELATED DB: PDB REMARK 900 RELATED ID: 5VD3 RELATED DB: PDB DBREF 5VCY A 75 362 UNP Q99640 PMYT1_HUMAN 75 362 SEQADV 5VCY MET A -22 UNP Q99640 INITIATING METHIONINE SEQADV 5VCY HIS A -21 UNP Q99640 EXPRESSION TAG SEQADV 5VCY HIS A -20 UNP Q99640 EXPRESSION TAG SEQADV 5VCY HIS A -19 UNP Q99640 EXPRESSION TAG SEQADV 5VCY HIS A -18 UNP Q99640 EXPRESSION TAG SEQADV 5VCY HIS A -17 UNP Q99640 EXPRESSION TAG SEQADV 5VCY HIS A -16 UNP Q99640 EXPRESSION TAG SEQADV 5VCY SER A -15 UNP Q99640 EXPRESSION TAG SEQADV 5VCY SER A -14 UNP Q99640 EXPRESSION TAG SEQADV 5VCY GLY A -13 UNP Q99640 EXPRESSION TAG SEQADV 5VCY VAL A -12 UNP Q99640 EXPRESSION TAG SEQADV 5VCY ASP A -11 UNP Q99640 EXPRESSION TAG SEQADV 5VCY LEU A -10 UNP Q99640 EXPRESSION TAG SEQADV 5VCY GLY A -9 UNP Q99640 EXPRESSION TAG SEQADV 5VCY THR A -8 UNP Q99640 EXPRESSION TAG SEQADV 5VCY GLU A -7 UNP Q99640 EXPRESSION TAG SEQADV 5VCY ASN A -6 UNP Q99640 EXPRESSION TAG SEQADV 5VCY LEU A -5 UNP Q99640 EXPRESSION TAG SEQADV 5VCY TYR A -4 UNP Q99640 EXPRESSION TAG SEQADV 5VCY PHE A -3 UNP Q99640 EXPRESSION TAG SEQADV 5VCY GLN A -2 UNP Q99640 EXPRESSION TAG SEQADV 5VCY SER A 73 UNP Q99640 EXPRESSION TAG SEQADV 5VCY MET A 74 UNP Q99640 EXPRESSION TAG SEQRES 1 A 311 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 311 GLY THR GLU ASN LEU TYR PHE GLN SER MET HIS GLN LEU SEQRES 3 A 311 GLN PRO ARG ARG VAL SER PHE ARG GLY GLU ALA SER GLU SEQRES 4 A 311 THR LEU GLN SER PRO GLY TYR ASP PRO SER ARG PRO GLU SEQRES 5 A 311 SER PHE PHE GLN GLN SER PHE GLN ARG LEU SER ARG LEU SEQRES 6 A 311 GLY HIS GLY SER TYR GLY GLU VAL PHE LYS VAL ARG SER SEQRES 7 A 311 LYS GLU ASP GLY ARG LEU TYR ALA VAL LYS ARG SER MET SEQRES 8 A 311 SER PRO PHE ARG GLY PRO LYS ASP ARG ALA ARG LYS LEU SEQRES 9 A 311 ALA GLU VAL GLY SER HIS GLU LYS VAL GLY GLN HIS PRO SEQRES 10 A 311 CYS CYS VAL ARG LEU GLU GLN ALA TRP GLU GLU GLY GLY SEQRES 11 A 311 ILE LEU TYR LEU GLN THR GLU LEU CYS GLY PRO SER LEU SEQRES 12 A 311 GLN GLN HIS CYS GLU ALA TRP GLY ALA SER LEU PRO GLU SEQRES 13 A 311 ALA GLN VAL TRP GLY TYR LEU ARG ASP THR LEU LEU ALA SEQRES 14 A 311 LEU ALA HIS LEU HIS SER GLN GLY LEU VAL HIS LEU ASP SEQRES 15 A 311 VAL LYS PRO ALA ASN ILE PHE LEU GLY PRO ARG GLY ARG SEQRES 16 A 311 CYS LYS LEU GLY ASP PHE GLY LEU LEU VAL GLU LEU GLY SEQRES 17 A 311 THR ALA GLY ALA GLY GLU VAL GLN GLU GLY ASP PRO ARG SEQRES 18 A 311 TYR MET ALA PRO GLU LEU LEU GLN GLY SER TYR GLY THR SEQRES 19 A 311 ALA ALA ASP VAL PHE SER LEU GLY LEU THR ILE LEU GLU SEQRES 20 A 311 VAL ALA CYS ASN MET GLU LEU PRO HIS GLY GLY GLU GLY SEQRES 21 A 311 TRP GLN GLN LEU ARG GLN GLY TYR LEU PRO PRO GLU PHE SEQRES 22 A 311 THR ALA GLY LEU SER SER GLU LEU ARG SER VAL LEU VAL SEQRES 23 A 311 MET MET LEU GLU PRO ASP PRO LYS LEU ARG ALA THR ALA SEQRES 24 A 311 GLU ALA LEU LEU ALA LEU PRO VAL LEU ARG GLN PRO HET DB8 A 401 65 HET EDO A 402 10 HET EDO A 403 10 HET EDO A 404 10 HET PEG A 405 17 HET DMS A 406 10 HETNAM DB8 4-[(2,4-DICHLORO-5-METHOXYPHENYL)AMINO]-6-METHOXY-7-[3- HETNAM 2 DB8 (4-METHYLPIPERAZIN-1-YL)PROPOXY]QUINOLINE-3- HETNAM 3 DB8 CARBONITRILE HETNAM EDO 1,2-ETHANEDIOL HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM DMS DIMETHYL SULFOXIDE HETSYN DB8 BOSUTINIB HETSYN EDO ETHYLENE GLYCOL FORMUL 2 DB8 C26 H29 CL2 N5 O3 FORMUL 3 EDO 3(C2 H6 O2) FORMUL 6 PEG C4 H10 O3 FORMUL 7 DMS C2 H6 O S FORMUL 8 HOH *237(H2 O) HELIX 1 AA1 ASP A -11 GLU A -7 5 5 HELIX 2 AA2 SER A 104 SER A 109 1 6 HELIX 3 AA3 GLY A 147 GLY A 165 1 19 HELIX 4 AA4 SER A 193 GLY A 202 1 10 HELIX 5 AA5 PRO A 206 GLN A 227 1 22 HELIX 6 AA6 LYS A 235 ALA A 237 5 3 HELIX 7 AA7 PRO A 243 GLY A 245 5 3 HELIX 8 AA8 ASP A 270 MET A 274 5 5 HELIX 9 AA9 ALA A 275 GLY A 281 5 7 HELIX 10 AB1 THR A 285 ASN A 302 1 18 HELIX 11 AB2 GLY A 308 ARG A 316 1 9 HELIX 12 AB3 PRO A 321 ALA A 326 1 6 HELIX 13 AB4 SER A 329 LEU A 340 1 12 HELIX 14 AB5 THR A 349 ALA A 355 1 7 HELIX 15 AB6 LEU A 356 ARG A 360 5 5 SHEET 1 AA1 6 ARG A 80 ARG A 81 0 SHEET 2 AA1 6 LEU A 173 GLU A 179 -1 O GLU A 178 N ARG A 80 SHEET 3 AA1 6 ILE A 182 GLU A 188 -1 O TYR A 184 N TRP A 177 SHEET 4 AA1 6 LEU A 135 SER A 141 -1 N ALA A 137 O THR A 187 SHEET 5 AA1 6 GLY A 122 SER A 129 -1 N GLU A 123 O ARG A 140 SHEET 6 AA1 6 PHE A 110 GLY A 119 -1 N GLN A 111 O ARG A 128 SHEET 1 AA2 2 LEU A 229 VAL A 230 0 SHEET 2 AA2 2 VAL A 256 GLU A 257 -1 O VAL A 256 N VAL A 230 SHEET 1 AA3 2 ILE A 239 LEU A 241 0 SHEET 2 AA3 2 CYS A 247 LEU A 249 -1 O LYS A 248 N PHE A 240 CISPEP 1 ALA A 88 SER A 89 0 4.46 CISPEP 2 ALA A 261 GLY A 262 0 -1.10 SITE 1 AC1 17 LEU A 116 ALA A 137 VAL A 138 LYS A 139 SITE 2 AC1 17 GLU A 157 VAL A 171 LEU A 185 THR A 187 SITE 3 AC1 17 GLU A 188 CYS A 190 GLY A 191 GLN A 196 SITE 4 AC1 17 ASN A 238 PHE A 240 DMS A 406 HOH A 617 SITE 5 AC1 17 HOH A 619 SITE 1 AC2 4 GLU A 310 GLN A 314 GLU A 331 HOH A 584 SITE 1 AC3 4 PRO A 148 PHE A 324 EDO A 404 HOH A 670 SITE 1 AC4 4 PHE A 145 GLY A 181 EDO A 403 HOH A 652 SITE 1 AC5 4 SER A 114 ARG A 115 GLN A 313 HOH A 564 SITE 1 AC6 4 LYS A 139 ASP A 251 DB8 A 401 HOH A 501 CRYST1 46.630 55.000 113.660 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021445 0.000000 0.000000 0.00000 SCALE2 0.000000 0.018182 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008798 0.00000